¼¼°èÀÇ °£Áú ¼ö¼ú ½ÃÀå
Epilepsy Surgery
»óǰÄÚµå : 1757716
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 268 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,053,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,161,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

°£Áú ¼ö¼ú ¼¼°è ½ÃÀåÀº 2030³â±îÁö 6¾ï 4,320¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 5¾ï 390¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â °£Áú ¼ö¼ú ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 6¾ï 4,320¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ 2024-2030³â CAGRÀº 4.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ´ëÀÎ ¼ö¼úÀº CAGR 4.8%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 4¾ï 6,280¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ·¹ÀÌÀú °£Áú¼º ¿Â¿­¿ä¹ý ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 2.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 3,730¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ °£Áú ¼ö¼ú ½ÃÀåÀº 2024³â¿¡ 1¾ï 3,730¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 1¾ï 3,240¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 7.7%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.6%¿Í 3.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ °£Áú ¼ö¼ú ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

°£Áú ¼ö¼úÀÌ ¾à¹° ³»¼º ¹ßÀÛÀÇ È®½ÇÇÑ Ä¡·á ¿É¼ÇÀ¸·Î °¢±¤¹Þ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

°£Áú ¼ö¼úÀº ¾à¹° ³»¼º °£Áú Ä¡·áÁ¦·Î ÀÎÁ¤¹Þ°í ÀÖÀ¸¸ç, Ç×°£Áú¾à¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â ¼ö¹é¸¸ ¸íÀÇ È¯Àڵ鿡°Ô Èñ¸ÁÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¾à¹° Ä¡·á°¡ ¿©ÀüÈ÷ ù ¹øÂ° ¼±ÅÃÀÌÁö¸¸, °£Áú ȯÀÚÀÇ ¾à 3ºÐÀÇ 1Àº ¿©·¯ °¡Áö ¾à¹°À» ½ÃµµÇßÀ½¿¡µµ ºÒ±¸ÇÏ°í ¹ßÀÛÀÌ Á¶ÀýµÇÁö ¾Ê¾Æ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯Àڵ鿡°Ô °£Áú ¼ö¼úÀº °£Áú ¹ßÀÛÀ» À¯¹ßÇÏ´Â ³úÀÇ Æ¯Á¤ ºÎÀ§¸¦ Ç¥ÀûÀ¸·Î »ï´Â °£Áú ¼ö¼úÀº »îÀ» º¯È­½Ãų ¼ö ÀÖ´Â ¼±ÅÃÁö¸¦ Á¦°øÇÕ´Ï´Ù. ´ë³ú¿±ÀýÁ¦¼ú, º´¼ÒÀýÁ¦¼ú, ³ú·®ÀýÁ¦¼ú, ¹Ý±¸ÀýÁ¦¼ú°ú °°Àº ¼ö¼úÀû °³ÀÔÀº ¹ßÀÛÀÇ ÃÊÁ¡À» Á¦°ÅÇϰųª ºÐ¸®ÇÏ¿© ¹ßÀÛÀÇ ÀüÆÄ¸¦ ¸·´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. °íÇØ»óµµ MRI, PET ½ºÄµ, ºñµð¿À ³úÆÄ ¸ð´ÏÅ͸µ°ú °°Àº ¿µ»ó ±â¼úÀÇ Çâ»óÀ¸·Î ¿Ü°ú ÀÇ»ç´Â °£Áú À¯¹ß ±¸¿ªÀ» Á¤È®ÇÏ°Ô ½Äº°ÇÒ ¼ö ÀÖ°Ô µÇ¾î ¼ö¼úÀÇ Á¤È®¼º°ú ¾ÈÀü¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ÀûÀýÇÏ°Ô ¼±ÅÃµÈ È¯ÀÚÀÇ ¼º°ø·üÀº 70-80%·Î ³ôÀ¸¸ç, °£Áú ¼ö¼úÀº ¹ßÀÛ ºóµµ¸¦ ÁÙÀÌ°í ¾à¹° ÀÇÁ¸µµ¸¦ ÃÖ¼ÒÈ­Çϸç ÀÎÁö ¹× ½É¸®»çȸÀû ±â´ÉÀ» Çâ»ó½ÃÄÑ »îÀÇ ÁúÀ» Å©°Ô Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÇ·áÁø°ú ȯÀÚµé »çÀÌ¿¡¼­ ¼ö¼úÀÇ ÀáÀçÀû À¯¿ë¼º¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó, ƯÈ÷ Áúº´ °æ°ú Ãʱ⿡ ¼ö¼úÀÇ À¯¿ë¼º¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °£Áú ¼¾ÅÍ¿¡ ´ëÇÑ ¼ö¼ú Àü Æò°¡ ÀÇ·Ú°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­·Î ÀÎÇØ °£Áú ¼ö¼úÀº ÃÖÈÄÀÇ ¼ö´ÜÀÌ ¾Æ´Ñ Àå±âÀûÀÎ ¹ßÀÛ ¾ïÁ¦¿Í ½Å°æÇÐÀû ȸº¹À» ´Þ¼ºÇϱâ À§ÇÑ Àû±ØÀûÀÎ Àü·«À¸·Î ÀÓ»ó¿¡¼­ ÁÖ·ù·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº °£Áú ¼ö¼úÀÇ Á¤È®¼º°ú ¾ÈÀü¼ºÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±â¼ú Çõ½ÅÀº °£Áú ¼ö¼úÀÇ »óȲÀ» ÀçÁ¤ÀÇÇϰí, ´õ Á¤È®Çϰí, ´ú ħ½ÀÀûÀ̸ç, ´õ ±¤¹üÀ§ÇÏ°Ô ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ½Å°æ¿µ»ó°ú Àü±â»ý¸®ÇÐÀû ¸ÅÇÎÀÇ ¹ßÀüÀ¸·Î ³ú ±â´É, ¿¬°á¼º, ¹ßÀÛ ¹ß»ý ÁöÁ¡¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ÀÌÇØ°¡ °¡´ÉÇØÁ³½À´Ï´Ù. ±â´ÉÀû MRI(fMRI), ³ú ÀÚ±â°ø¸í¿µ»ó(MEG), ÀÔü ³úÆÄ(SEEG)´Â °íÇØ»óµµ, ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇϸç, ¶Ù¾î³­ ƯÀ̼ºÀ¸·Î ¼ö¼ú °èȹÀ» ¼ö¸³ÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ¾ç»óÀº ¾ð¾î, ¿îµ¿, ±â¾ï¿¡ Áß¿äÇÑ ÇÇÁú ¿µ¿ª(¾ð¾î, ¿îµ¿, ±â¾ï¿¡ Áß¿äÇÑ ¿µ¿ª)À» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µÇ¹Ç·Î, ¿Ü°úÀÇ»ç´Â ¹ßÀÛ º´º¯À» Ç¥ÀûÀ¸·Î »ïÀ¸¸é¼­µµ Áß¿äÇÑ ±â´ÉÀ» º¸Á¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ·¹ÀÌÀú °£Áú ¿­Ä¡·á(LITT)¿Í °°Àº ÃÖ¼Òħ½ÀÀû Á¢±Ù¹ýÀº MRI À¯µµÇÏ ·¹ÀÌÀú¸¦ »ç¿ëÇÏ¿© °£Áú À¯¹ß Á¶Á÷À» ÀýÁ¦ÇÏ¿© ÁÖº¯ Àå¾Ö¸¦ ÃÖ¼ÒÈ­Çϰí Á¶±â ȸº¹°ú ¼ö¼ú À§Çè °¨¼Ò¸¦ ½ÇÇöÇÕ´Ï´Ù. ·Îº¿ º¸Á¶ ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀº Àü±Ø ¹èÄ¡ ¹× º´º¯ ÀýÁ¦ ½Ã ¹Ð¸®¹ÌÅÍ ´ÜÀ§ÀÇ Á¤¹Ðµµ¸¦ °¡´ÉÇÏ°Ô ÇÏ¿© Á¤È®µµ¸¦ ´õ¿í ³ôÀÔ´Ï´Ù. ¹ÝÀÀ¼º ½Å°æÀÚ±Ø(RNS)À̳ª ½ÉºÎ ³úÀÚ±Ø(DBS)°ú °°Àº ½Å°æÁ¶Àý ÀåÄ¡µµ ƯÈ÷ ´Ù¹ß¼º ¶Ç´Â ºñ±¹¼Ò¼º °£Áú ȯÀÚ¿¡¼­ ÀýÁ¦ ¼ö¼úÀÇ ´ë¾ÈÀ¸·Î °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ ÀåÄ¡´Â ³úÀÇ È°µ¿À» Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ°í ¹ßÀÛÀ» ¿¹¹æÇϱâ À§ÇÑ Ç¥Àû Àü±â ÀÚ±ØÀ» ½Ç½Ã°£À¸·Î °ø±ÞÇÕ´Ï´Ù. ¼ö¼ú Àü Æò°¡¿¡ ÀΰøÁö´É°ú ¸Ó½Å·¯´×À» µµÀÔÇÏ¿© ȯÀÚ ¼±Åðú °á°ú ¿¹ÃøÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû ¹ßÀüÀº °£Áú ¼ö¼úÀÌ ´Þ¼ºÇÒ ¼ö ÀÖ´Â ÇѰ踦 ³ÐÈ÷°í, À§ÇèÀ» ÁÙÀ̰í, ÀûÀÀÁõÀ» È®´ëÇϸç, ±Ã±ØÀûÀ¸·Î ´õ ¸¹Àº ȯÀÚ¿¡°Ô ¼ö¼úÀû °³ÀÔÀ» ½ÇÇà °¡´ÉÇÑ ¿É¼ÇÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù.

°£Áú ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ´Ù¾çÇÑ ¿¬·ÉÃþ°ú ¼¼°è °¢Áö¿¡¼­ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

Àü ¼¼°èÀûÀ¸·Î °£Áú ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â ´Ù¾çÇÑ ¿¬·ÉÃþ°ú Áö¿ª¿¡ °ÉÃÄ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Áø´Ü ´É·ÂÀÇ Çâ»ó°ú ¼ö¼úÀû °³ÀÔ¿¡ ´ëÇÑ ÀÓ»óÀû °üÁ¡ÀÇ º¯È­¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. ¼Ò¾ÆÀÇ °æ¿ì, ³ú°¡ ¼º¼÷ÇÏ´Â Áß¿äÇÑ ½Ã±â¿¡ ¹ßÀÛÀÌ Áö¼ÓµÇ¾î ¹ß»ýÇÏ´Â ÀÎÁö ¹× ¹ß´Þ Áö¿¬À» ¿¹¹æÇϱâ À§ÇØ Á¶±â ¼ö¼úÀÌ ±ÇÀåµÇ°í ÀÖ½À´Ï´Ù. ¼Ò¾Æº´¿ø°ú °£Áú¼¾ÅÍ´Â º¹ÀâÇÑ °£Áú ÁõÈıºÀ» °¡Áø ¾î¸° ȯÀÚµéÀ» Æò°¡ÇÏ°í ¼ö¼úÇÒ ¼ö ÀÖ´Â Àü¹® ÆÀ°ú µµ±¸¸¦ °®Ãß°í ÀÖ½À´Ï´Ù. ¼ºÀÎ, ƯÈ÷ ÇÑâ ÀÏÇϰųª °¡ÀÓ±âÀΠȯÀÚÀÇ °æ¿ì, °£Áú ¹ßÀÛ¿¡¼­ ¹þ¾î³ª´Â °ÍÀº µ¶¸³¼º, °í¿ë, °¡Á¤»ýȰ¿¡ Áß´ëÇÑ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î 5,000¸¸ ¸í ÀÌ»óÀÌ ¾Î°í ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µÇ´Â °£ÁúÀÇ À¯º´·üÀº °è¼Ó Áõ°¡Çϰí ÀÖÀ¸¸ç, ¾àÁ¦ ³»¼ºÀ» °¡Áø ȯÀÚµµ »ó´ç¼ö Á¸ÀçÇϱ⠶§¹®¿¡ Á¢±Ù¼ºÀÌ ÁÁ°í È¿°úÀûÀÎ ¼ö¼úÀû Ä¡·áÀÇ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. °í¼Òµæ ±¹°¡¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶ó¿Í º¸ÇèÀÌ Àß °®Ãß¾îÁ® ÀÖ¾î ¼ö¼úÀû Ä¡·áÀÇ µµÀÔÀÌ È°¹ßÈ÷ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÇÑÆí, ½ÅÈï±¹¿¡¼­´Â Á¤ºÎÀÇ ÀÇ·á ÀÌ´Ï¼ÅÆ¼ºê, ¿ø°ÝÀÇ·á Çù·Â, ¼¼°è ±³À° ÆÄÆ®³Ê½Ê¿¡ ÈûÀÔ¾î ½Å°æ¿Ü°ú ¼ö¼ú ¿ª·®ÀÌ Á¡Â÷ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À̵¿½Ä ³úÆÄ°è, À§¼º °£Áú Ŭ¸®´Ð, ±¹Á¦ NGOÀÇ Áö¿øµµ ¼Ò¿ÜµÈ Áö¿ªÀÇ Ä¡·á °ÝÂ÷¸¦ ÇØ¼ÒÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. °£Áú¿¡ ´ëÇÑ »çȸÀû ÀνÄÀÌ ³ô¾ÆÁö°í Æí°ßÀÌ ÁÙ¾îµé¸é¼­ ´õ ¸¹Àº ȯÀÚµéÀÌ Àü¹® ±â°ü¿¡¼­ Æò°¡¸¦ ¹ÞÀ¸·Á´Â °æÇâÀÌ ³ô¾ÆÁ³°í, ÀÌ´Â ¼ö¼ú Èĺ¸ÀÚ¸¦ Á¶±â¿¡ ¹ß±¼ÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â °£Áú ¼ö¼úÀÌ ´Ü¼øÇÑ Æ´»õ Ä¡·á¹ýÀÌ ¾Æ´Ï¶ó Á¾ÇÕÀûÀÎ °£Áú Ä¡·áÀÇ ÇÙ½É ¿ä¼Ò¶ó´Â Àü ¼¼°èÀûÀÎ °ø°¨´ë°¡ Çü¼ºµÇ°í ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù.

Àü ¼¼°è °£Áú ¼ö¼ú ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÈ­ÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?

°£Áú ¼ö¼ú ½ÃÀåÀÇ ¼ºÀåÀº ÀÓ»óÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿äÀÎÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ³­Ä¡¼º °£Áú Ä¡·á¿¡ ´ëÇÑ º¸´Ù Àû±ØÀûÀÎ Á¢±Ù¹ýÀ» °¡¸®Å°°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â °£Áú À¯º´·üÀÇ Áõ°¡¿Í ¾à¹° Ä¡·á¿¡ ³»¼ºÀ» º¸À̴ ȯÀÚ ºñÀ²ÀÇ Áõ°¡ÀÔ´Ï´Ù. ¹Ì±¹½Å°æÇÐȸ(AAN)¿Í ±¹Á¦³úÀüÁõ¿¬¸Í(ILAE)°ú °°Àº ±ÇÀ§ ÀÖ´Â ´ÜüÀÇ ÀÓ»ó °¡À̵å¶óÀÎÀº ÇöÀç ¾à¹° ³»¼º ȯÀÚ¿¡ ´ëÇÑ Á¶±â ¼ö¼úÀû Æò°¡¸¦ ±ÇÀåÇϰí ÀÖÀ¸¸ç, Á¶±â °³ÀÔ°ú Àå±âÀûÀÎ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖµµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ ¼ö¼ú¿¡ µû¸¥ À§ÇèÀÌ Å©°Ô °¨¼ÒÇÏ¿© ÀÌÀüº¸´Ù ´õ ¾ÈÀüÇϰí È¿°úÀûÀÎ ¼±ÅÃÀÌ µÇ¾ú½À´Ï´Ù. Àü ¼¼°è ÀÇ·á ±â°üµéÀº ÷´Ü Áø´Ü, ¼ö¼ú °èȹ, ¼ö¼ú ÈÄ ÀçȰÀ» Á¦°øÇÒ ¼ö ÀÖ´Â ´ÙÇÐÁ¦ ÆÀÀ» °®Ãá Á¾ÇÕ °£Áú ¼¾ÅÍ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹, µ¶ÀÏ, ÀϺ» µîÀÇ ±¹°¡¿¡¼­´Â º¸Çè Àû¿ë È®´ë¿Í À¯¸®ÇÑ »óȯ Á¤Ã¥À¸·Î ÀÎÇØ ÀÇ·á Á¦°øÀÚ°¡ ȯÀÚ¸¦ ¼ö¼úÀû Æò°¡¿¡ ÀÇ·ÚÇÒ ¼ö ÀÖ´Â Àμ¾Æ¼ºê°¡ ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù. Á¦¾àȸ»ç ¹× ÀÇ·á±â±â Á¦Á¶¾÷üµéµµ À̽ÄÇü ½Å°æ Àڱرâ, ½Ç½Ã°£ ³ú ¸ÅÇÎ µµ±¸ µîÀÇ Áö¿ø ±â¼úÀ» °¡Áö°í ÀÌ ºÐ¾ß¿¡ ÁøÃâÇÏ¿© º¸´Ù ÅëÇÕÀûÀÎ Ä¡·á »ýŰ踦 ±¸ÃàÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »îÀÇ Áú(QOL), ±³À° ¼ºÃëµµ, Á¤½Å°Ç°­ µî ȯÀÚ Áß½ÉÀÇ °á°ú°¡ Áß¿äÇØÁö¸é¼­ ÀÓ»ó ¸ñÇ¥°¡ ¹ßÀÛ ¿ÏÈ­¿¡¼­ ÀüÀÎÀû ÇູÀ¸·Î ¿Å°Ü°¡°í ÀÖÀ¸¸ç, °áÁ¤ÀûÀÎ ¼ö¼úÀû ¼Ö·ç¼ÇÀÇ °¡Ä¡°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â °£Áú ¼ö¼ú ½ÃÀåÀÇ °ß°íÇϰí Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÃËÁøÇÏ°í ¹Ì·¡ ½Å°æÇÐ Ä¡·áÀÇ Áß¿äÇÑ ÃàÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

À¯Çü(´ëÀÎ ¼ö¼ú, ·¹ÀÌÀú °£Áú¼º ¿Â¿­¿ä¹ý), ¿ëµµ(º´¿ø ¹× Ŭ¸®´Ð, Àü¹® ¼¾ÅÍ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 34°³»ç)

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× »ê¾÷º° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Epilepsy Surgery Market to Reach US$643.2 Million by 2030

The global market for Epilepsy Surgery estimated at US$503.9 Million in the year 2024, is expected to reach US$643.2 Million by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Respective Surgery, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$462.8 Million by the end of the analysis period. Growth in the Laser Interstitial Thermal Therapy segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$137.3 Million While China is Forecast to Grow at 7.7% CAGR

The Epilepsy Surgery market in the U.S. is estimated at US$137.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$132.4 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Epilepsy Surgery Market - Key Trends & Drivers Summarized

Why Is Epilepsy Surgery Gaining Momentum as a Definitive Treatment Option for Drug-Resistant Seizures?

Epilepsy surgery is increasingly recognized as a transformative and potentially curative treatment for individuals with drug-resistant epilepsy, offering hope to millions who fail to respond to antiepileptic medications. While pharmacological treatment remains the first line of therapy, nearly one-third of epilepsy patients continue to suffer from uncontrolled seizures despite trying multiple drugs. For this population, epilepsy surgery offers a life-changing alternative by targeting the specific area of the brain responsible for seizure activity. Surgical interventions, such as lobectomy, lesionectomy, corpus callosotomy, and hemispherectomy, are aimed at either removing or disconnecting the seizure focus, thereby halting seizure propagation. Improved imaging technologies, such as high-resolution MRI, PET scans, and video EEG monitoring, now enable surgeons to precisely locate epileptogenic zones, improving surgical accuracy and safety. With success rates as high as 70-80% in appropriately selected patients, epilepsy surgery can dramatically improve quality of life by reducing seizure frequency, minimizing medication dependency, and enhancing cognitive and psychosocial function. As awareness grows among healthcare providers and patients about the potential benefits of surgery, especially when offered early in the disease course, more referrals are being made to epilepsy centers for pre-surgical evaluation. This shift is propelling epilepsy surgery into mainstream clinical consideration, not as a last resort but as a proactive strategy to achieve long-term seizure control and neurological recovery.

How Are Technological Advancements Elevating the Precision and Safety of Epilepsy Surgery?

Technological innovation is redefining the landscape of epilepsy surgery, making procedures more accurate, less invasive, and broadly accessible. Advancements in neuroimaging and electrophysiological mapping now enable a comprehensive understanding of brain function, connectivity, and seizure origination points. Functional MRI (fMRI), magnetoencephalography (MEG), and stereo-electroencephalography (SEEG) provide high-resolution, real-time data that guide surgical planning with remarkable specificity. These modalities help identify eloquent cortex regions-areas critical for speech, movement, and memory-thus allowing surgeons to preserve key functions while targeting seizure foci. Minimally invasive approaches, such as laser interstitial thermal therapy (LITT), use MRI-guided lasers to ablate epileptogenic tissue with minimal disruption to surrounding areas, offering faster recovery and reduced surgical risks. Robot-assisted navigation systems further enhance precision, enabling millimeter-level accuracy during electrode placement or lesion resection. Neuromodulation devices like responsive neurostimulation (RNS) and deep brain stimulation (DBS) are also gaining traction as alternatives to resective surgery, particularly in patients with multifocal or non-localizable epilepsy. These devices continuously monitor brain activity and deliver targeted electrical impulses to prevent seizures in real time. The incorporation of artificial intelligence and machine learning into pre-surgical assessments is also improving patient selection and outcome prediction. Collectively, these technological advances are pushing the boundaries of what epilepsy surgery can achieve-reducing risks, expanding indications, and ultimately making surgical intervention a viable option for a broader patient population.

Why Is the Demand for Epilepsy Surgery Increasing Across Different Age Groups and Global Regions?

The global demand for epilepsy surgery is rising across diverse age groups and geographic regions, reflecting both improved diagnostic capabilities and changing clinical perspectives on surgical intervention. In pediatric populations, early surgery is now being recommended to prevent the cognitive and developmental delays often caused by persistent seizures during critical brain maturation periods. Children's hospitals and epilepsy centers are increasingly equipped with specialized teams and tools to assess and operate on young patients with complex epilepsy syndromes. In adults, particularly those in the workforce or reproductive years, the goal of achieving seizure freedom has profound implications for independence, employment, and family life. The growing prevalence of epilepsy-estimated to affect over 50 million people worldwide-combined with a significant subset of drug-resistant cases, underscores the need for accessible and effective surgical treatments. In high-income countries, enhanced healthcare infrastructure and insurance coverage are facilitating greater uptake of surgical options. Meanwhile, emerging economies are gradually expanding their neurosurgical capabilities, driven by government health initiatives, telemedicine collaborations, and global training partnerships. Mobile EEG units, satellite epilepsy clinics, and international NGO support are also helping to bridge the treatment gap in under-resourced areas. As public awareness increases and stigma around epilepsy diminishes, more individuals are seeking evaluation at specialized centers, leading to earlier identification of surgical candidates. These trends highlight a growing global consensus that epilepsy surgery is not just a niche procedure but a critical component of comprehensive epilepsy care.

What Key Factors Are Driving the Accelerated Growth of the Epilepsy Surgery Market Globally?

The growth in the epilepsy surgery market is driven by a confluence of clinical, technological, societal, and economic factors that collectively point to a more proactive approach in treating refractory epilepsy. One of the key drivers is the rising prevalence of epilepsy and the significant proportion of patients who remain resistant to medication, creating a substantial pool of surgical candidates. Clinical guidelines from authoritative bodies like the American Academy of Neurology (AAN) and the International League Against Epilepsy (ILAE) now recommend early surgical evaluation for drug-resistant patients, encouraging earlier intervention and better long-term outcomes. Technological innovation has significantly lowered the risks associated with surgery, making it a safer and more effective option than in the past. Health systems worldwide are investing in comprehensive epilepsy centers with multidisciplinary teams capable of delivering advanced diagnostics, surgical planning, and postoperative rehabilitation. Increasing insurance coverage and favorable reimbursement policies in countries such as the U.S., Germany, and Japan are further incentivizing healthcare providers to refer patients for surgical assessment. Pharmaceutical companies and medical device manufacturers are also entering the space with supportive technologies, such as implantable neurostimulators and real-time brain mapping tools, creating a more integrated ecosystem of care. Additionally, the growing emphasis on patient-centered outcomes-such as quality of life, educational attainment, and mental health-has shifted clinical goals from seizure reduction alone to holistic well-being, reinforcing the value of definitive surgical solutions. These converging trends are catalyzing robust and sustained growth in the epilepsy surgery market, positioning it as a key pillar in the future of neurological treatment.

SCOPE OF STUDY:

The report analyzes the Epilepsy Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Respective Surgery, Laser Interstitial Thermal Therapy); Application (Hospitals & Clinics, Specialty Centers, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â